Bronkometer Uses, Dosage, Interactions & Side Effects

Introduction to Bronkometer

Bronkometer, also known by the generic name isoetharine, is a bronchodilator medication used for the treatment of respiratory conditions such as emphysema, bronchitis, and asthma. It belongs to the class of drugs called adrenergic beta-2 agonists, which work by relaxing the muscles in the airways to improve breathing.

Chemical Composition

The chemical formula of bronkometer is C14H25NO6S. Its PubChem Compound Identification (CID) number is 76972622.

Usage and Applications

Bronkometer is primarily used as a fast-acting bronchodilator for the treatment of lung diseases characterized by airway obstruction, such as chronic obstructive pulmonary disease (COPD), emphysema, bronchitis, and asthma. It helps alleviate symptoms like shortness of breath, wheezing, and chest tightness by relaxing and opening the airways.

Mechanism of Action

As an adrenergic beta-2 agonist, bronkometer acts by stimulating the beta-2 receptors in the lungs, which leads to the relaxation of bronchial smooth muscles. This bronchodilation effect increases airflow, making it easier to breathe. The drug is rapidly absorbed and starts acting within minutes of inhalation.

Clinical Information

Bronkometer is classified under the American Hospital Formulary Service (AHFS) Pharmacologic- Therapeutic Classification and has the Anatomical Therapeutic Chemical (ATC) code R03AC07 as per the World Health Organization (WHO) classification system.

Dosage Forms and Strengths

Bronkometer is available as an inhalation solution in various concentrations. The typical dosage is 1-3 inhalations every 3-4 hours, depending on the severity of the condition and individual response. It is important to follow the prescribed dosage instructions carefully.

Comparisons with Other Bronchodilators

Bronkometer has been compared with other bronchodilators like isoetharine, isoproterenol, and phenylephrine in various clinical studies. While it has shown similar efficacy, bronkometer may have a slightly different side effect profile and duration of action compared to some of these drugs.

Side Effects

Common side effects of bronkometer include headache, dizziness, lightheadedness, and insomnia. More severe and long-term side effects may include tremor, nervousness, sweating, nausea, vomiting, diarrhea, and dry mouth. Consult a healthcare provider if side effects persist or worsen.

Contraindications and Precautions

Bronkometer should be used with caution in patients with cardiovascular disorders, hypertension, hyperthyroidism, or diabetes. It is contraindicated in individuals with known hypersensitivity to the drug or any of its components. Pregnant and breastfeeding women should consult their doctor before using bronkometer.

Drug Interactions

Bronkometer may interact with other medications, especially those containing phenylephrine or thenyldiamine. Concurrent use with monoamine oxidase inhibitors (MAOIs) should be avoided. Always inform your doctor about all the medications you are taking before starting bronkometer.

Legal and Regulatory Status

Bronkometer is a prescription medication in most countries. Its legal status and availability may vary depending on the specific regulations of each country.

Brand Names and Market Availability

Bronkometer is sold under various brand names, such as Bronkosol and Dilabron. Generic versions of the drug are also available in many countries.

Research and Clinical Studies

Several clinical studies have investigated the efficacy and safety of bronkometer in the management of respiratory conditions. A systematic review published in the Cochrane Database of Systematic Reviews concluded that bronkometer is effective in improving lung function and reducing symptoms in patients with COPD.

Historical Context and Development

Bronkometer was first developed in the mid-20th century as a synthetic bronchodilator. Over the years, it has undergone various formulation changes and improvements to enhance its efficacy and safety profile.

Patient Education and Management

Patients should be educated on the proper use of bronkometer inhalers, including the correct inhalation technique and adherence to the prescribed dosage schedule. Regular monitoring of lung function and symptom control is important to assess the effectiveness of the treatment.

Storage and Handling

Bronkometer should be stored at room temperature, away from heat, moisture, and direct light. The inhaler should be discarded after the expiration date or if the medication becomes discolored or cloudy.

References

1. National Center for Biotechnology Information. PubChem Compound Summary for CID 76972622, Isoetharine. Isoetharine“>https://pubchem.ncbi.nlm.nih.gov/compound/ Isoetharine . Accessed May 24, 2023.
2. Cazzola, M., Page, C. P., Rogliani, P., & Matera, M. G. (2013). β2-agonist therapy in lung disease. American journal of respiratory and critical care medicine, 187(7), 690-696. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678106/
3. Billington, C. K., Penn, R. B., & Hall, I. P. (2017). β2 Agonists. Handbook of experimental pharmacology, 237, 23-40. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627220/